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Pseudothrombophlebitic onset of
septic arthritis in a patient with
systemic lupus erythematosus
SIR, We read with interest the article by Dawes et al which
describes a case of gonococcal arthritis presenting as
pseudothrombophlebitis.' We have recently observed the
pseudothrombophlebitic onset of septic arthritis in a
patient with systemic lupus erythematosus (SLE).
The patient was a 34 year old woman with a 10 year
history of SLE which was controlled with prednisone 20 mg
daily. Six days before admission she experienced fever,
polyarthralgia, and a swollen right knee. Subsequently
there was a sudden onset of pain and swelling of the right
calf. Examination showed a febrile patient (axillary
temperature 38°C) in good general condition; there was
arthritis of the right knee joint and swelling of the adjacent
calf, suggesting popliteal cyst rupture. Ultrasound con-
firmed this clinical diagnosis. Fluid obtained from
arthrocentesis as well as from aspiration of the swollen calf
contained pus, which on culture grew Staphylococcus
aureus. Laboratory tests included an erythrocyte sedi-
mentation rate of 75 mm/lst h, haemoglobin 116 g/l, white
blood cell count 7.46x l09/l (differential count normal),
and normal routine blood biochemistry. Urine analysis
showed no proteinuria or other abnormalities. Blood
cultures were negative. Therapy was started with intra-
venous cloxacillin 12 g daily and multiple aspirations; since
the clinical picture did not clearly improve, arthrotomy and
drainage of the knee was carried out, resulting in a
satisfactory outcome.
Baker's cysts are an infrequent complication of SLE.
Thus Stevens points out that only 5% of his patients
showed this change,2 and in the series of 34 cases of
pseudothrombophlebitic syndrome (PTP) collected by
Katz et al only two had SLE. The association of PTP and
septic arthritis has been reported infrequently. 4' 5We are
aware of no cases of pseudothrombophlebitic onset of
septic arthritis reported in patients with SLE. We would
stress the usefulness of ultrasound in the diagnosis of this
clinical entity.6
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Book reviews
The Clinical Pharmacology of Anti-Inflammatory
Agents. By P M Brooks, W F Kean, W Watson
Buchanan. Pp. 150. £16.00. Taylor and Francis:
London. 1986.
This slim volume (150 pages, >i0p per page) aims to
provide a readable survey of drugs currently used in the
treatment of inflammatory joint disease. Opening chapters
on the pathogenesis of inflammation and its assessment are
followed by descriptions of individual anti-inflammatory
agents, in which their chemistry, pharmacology, toxicology,
and clinical effects are reviewed. Suggestions for further
reading are given at the end of each chapter (an unreason-
able proportion of which are to the authors' own publi-
cations!), but the book is otherwise entirely unreferenced.
The index is inadequate, a scant two pages.
It is difficult to decide for whom this book has been
written. Structural formulae abound and much of each
chapter is concerned with the chemistry and pharmaco-
kinetics of individual drugs, yet the approach is altogether
too superficial for the serious student of pharmacology. On
the other hand, detailed descriptions of drugs not yet
generally available (auranofin) or recently withdrawn from
sale (fenclofenac) are unlikely to be of great interest to the
practising rheumatologist. There are several areas of
inaccuracy (e.g., the physiology of the hypothalamic-
adrenal axis) and some of inadequate content (e.g., renal
effects of non-steroidal anti-inflammatory drugs); the units
used are American (e.g., mg/dl) and not English.
Although several weighty and highly expensive text-
books on anti-inflammatory drugs have been published
recently, there remains a need for a short, accurate, and
well referenced resume of currently used drugs. Unfortu-
nately this book does not fulfil that need.
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